Synaps Dx

0 followers


Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.

Employees

11-50

Links

Org chart

Frank Amato
President and CEO, Synaps Dx

Frank Amato

Collapse
John Harvey Saquilayan
Medical Laboratory Scientist - Team Lead
Julia Cochrane
Medical Laboratory Scientist
Elizabeth Enriquez
Medical Laboratory Scientist

Teams

This company has no teams yet